Therefore, developing effective therapeutics is vital and necessitates a comprehensive investigation into how these factors influence the pathological characteristics of AD, including amyloid plaque formation, tau pathology, and neuroinflammation. This evidence concerns the gene MAPT and Alzheimer disease.